[Alternative and innovative treatment methods. Who pays when federal insurance doesn't pay?].
Hirche
R A Wolfram
RA
D002648:Child; D000529:Complementary Therapies / Q000191:economics*; D016527:Drug Costs / Q000331:legislation & jurisprudence; D005251:Fees, Medical / Q000331:legislation & jurisprudence; D005858:Germany; D006801:Humans; D019458:Insurance Coverage / Q000191:economics*; D008297:Male; D020388:Muscular Dystrophy, Duchenne / Q000191:economics* / Q000628:therapy; D009313:National Health Programs / Q000191:economics*; D010879:Piperazines / Q000191:economics; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones
D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate
Ungewöhnliche und neuartige Behandlungsmethoden. Wer zahlt, wenn die Kasse nicht zahlt?